Effects of aspirin and Trapidil on cardiovascular events after Acute Myocardial Infarction

This publication has 15 references indexed in Scilit:

• A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor
  Published by Elsevier ,2002
• Aspirin Plus Either Dipyridamole or Ticlopidine is Effective in Preventing Recurrent Myocardial Infarction
  Japanese Circulation Journal, 1997
• A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents
  New England Journal of Medicine, 1996
• Antithrombotic Therapy in Children
  Chest, 1995
• Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica.
  Circulation, 1994
• The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction
  Progress in Cardiovascular Diseases, 1993
• Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.
  Circulation, 1993
• Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty
  American Heart Journal, 1992
• Secondary prevention of vascular disease by prolonged antiplatelet treatment
  BMJ, 1988
• Long-term prognosis of patients with acute myocardial infarction: Is mortality and mortidity as low as the incidence of ischemic heart disease in Japan?
  American Heart Journal, 1987